HEK293|360-HCP

HEK293 (human embryonic kidney 293) cells and their derived cell lines offer a particularly attractive heterologous system for developing recombinant proteins or producing adenoviruses. One key advantage is their ability to perform human-like posttranslational modifications of protein molecules, ensuring the desired biological activity of the final product. Furthermore, HEK293 cells exhibit a high transfection efficiency, leading to the production of high-quality recombinant proteins. Their ease of maintenance and efficient expression of membrane proteins, such as ion channels and transporters, make them an excellent choice for structural biology and electrophysiology studies. In line with our commitment to supporting advancements in bioengineering, we are pleased to offer our new HEK293|360-HCP ELISA, which is composed of a set of two generic kits.

The HEK293|360-HCP ELISA kits are each based on different sets of anti-HCP antibodies, developed by using either the supernatant (SN) or the cell lysate (CL) derived from HEK293 mock fermentation as antigen fractions for antibody generation, respectively.